Eli Lilly and Company (LLY) SEC Filings

Browse all Eli Lilly and Company SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more

Eli Lilly and Company Reports: Annual 10-K, Quarterly 10-Q & SEC Filings

SEC Filings

Date

8-K

Material company events (earnings, M&A, or leadership changes)

May 20, 2026

4

Insider ownership (buying, selling) activity

May 19, 2026

4

Insider ownership (buying, selling) activity

May 19, 2026

4

Insider ownership (buying, selling) activity

May 19, 2026

4

Insider ownership (buying, selling) activity

May 19, 2026

SD

Specialized disclosure report (e.g., conflict minerals)

May 11, 2026

424B2

Prospectus variant for specific offering structures

May 8, 2026

8-K

Material company events (earnings, M&A, or leadership changes)

May 7, 2026

4

Insider ownership (buying, selling) activity

May 7, 2026

424B2

Prospectus variant for specific offering structures

May 6, 2026

FWP

Free writing prospectus related to a securities offering

May 6, 2026

8-K

Material company events (earnings, M&A, or leadership changes)

Apr 30, 2026

10-Q

Quarterly financial results and management updates

Apr 30, 2026

PX14A6G

Shareholder proposal or communication exempt from proxy rules

Apr 29, 2026

4

Insider ownership (buying, selling) activity

Apr 21, 2026

4

Insider ownership (buying, selling) activity

Apr 21, 2026

4

Insider ownership (buying, selling) activity

Apr 21, 2026

4

Insider ownership (buying, selling) activity

Apr 21, 2026

SC 13G/A

Updated passive ownership disclosure

Apr 20, 2026

DFAN14A

Additional proxy materials filed by non-management parties

Mar 31, 2026

SC 13G/A

Updated passive ownership disclosure

Mar 26, 2026

DEF 14A

Final shareholder voting details (board elections and executive pay)

Mar 20, 2026

DEFA14A

Additional or supplemental proxy disclosures

Mar 20, 2026

4

Insider ownership (buying, selling) activity

Mar 17, 2026

4

Insider ownership (buying, selling) activity

Mar 17, 2026

4

Insider ownership (buying, selling) activity

Mar 17, 2026

4

Insider ownership (buying, selling) activity

Mar 17, 2026

PRE 14A

Preliminary proxy statement filed for SEC review

Mar 6, 2026

4

Insider ownership (buying, selling) activity

Feb 19, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

4

Insider ownership (buying, selling) activity

Feb 18, 2026

10-K

Annual financial results and management updates

Feb 12, 2026

4/A

Correction to a previously reported insider transaction

Feb 12, 2026

4

Insider ownership (buying, selling) activity

Feb 11, 2026

Eli Lilly and Company (Form 8-K) 2026

Current Events / Material company events (earnings, M&A, or leadership changes)

May 20, 2026

Sign in to view report